Understanding how a zygote develops from a single cell into a multicellular organism has benefitted from single-cell tools, including RNA sequencing (RNA-Seq) and immunofluorescence (IF). However, scrutinizing inter-and intra-embryonic phenotypic variation is hindered by two fundamental limitations; the loose correlation between transcription and translation and the cross-reactivity of immunoreagents. To address these challenges, we describe a high-specificity microfluidic immunoblot optimized to quantify protein expression from all stages of mouse preimplantation development. Despite limited availability of isoform-specific immunoreagents, the immunoblot resolves inter-embryonic heterogeneity of embryo-specific isoforms (i.e., DICER-1). We observed significantly higher DICER-1 isoform expression in oocytes when compared to two-cell embryos, and further find that protein expression levels follow the same trend as mRNA for both the full-length and truncated DICER-1 isoforms. At the morula stage, we assayed both whole and disaggregated embryos for loading controls (-tubulin, GAPDH) and markers that regulate cell fate decisions (CDX-2, SOX-2). In disaggregated morula, we found that cell volume showed positive, linear correlation with expression of -tubulin and SOX-2. In dissociated twocell and four-cell blastomeres, we detect significant inter-blastomeric variation in GADD45a expression, corroborating suspected cellular heterogeneity even in the earliest multicellular stage of preimplantation embryos. As RNA-Seq and other transcript-centric approaches continue to further probe preimplantation development, the demand for companion protein-based techniques rises. The reported microfluidic immunoblot serves as an essential tool for understanding mammalian development by providing high-specificity and direct measurements of protein targets at single-embryo and single-blastomere resolution.
Introduction
The initiating events and specific proteins involved in the first cell fate commitment within preimplantation blastomeres still remain open questions in developmental biology. While functional studies and embryonic plasticity suggest that blastomeres remain equivalent until the compacted morula [1] [2] [3] , growing evidence of inter-blastomeric differences in early-stage embryos point to heterogeneous configurations at even the earliest multicellular stages [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Although measurement tools with single-embryo and single-blastomere resolution, including RNA-Seq, have greatly advanced our knowledge, companion protein expression and state measurements within single embryos are required to test and validate these transcript-based predictions. Direct assessment of protein expression is required.
While immunofluorescence (IF) reports protein abundance and localization in embryos, IF is stymied by: (i) ubiquitous immunoreagent cross-reactivity that renders IF unsuitable for detection of small protein variations or multiplexing beyond ~5 targets 15 , (ii) proteoform 'blind spots' arising from limited isoform-specific immunoreagents that reduce the detectable repertoire of targets 16 , and (iii) confounding but required chemical fixation prior to IF measurement of endogenous intracellular proteins (i.e., epitope masking, cell morphology modifications, and perturbation of protein localization by diffusional gradients formed as fixation occurs) 17, 18 . Flow cytometry and mass cytometry suffer from similar specificity and fixation concerns as IF 19 . Mass spectrometry does not yet afford the sensitivity to analyze single-mouse embryos or blastomeres (tens of ng of protein in oocytes to < 1 ng of protein in blastomeres at the blastocyst stage) 19, 20 . Although protein analysis tools have been recently introduced to measure protein targets in single cells [21] [22] [23] [24] , fundamental differences between cultured cell lines and mammalian embryos have hindered the study of early mammalian development. Key differences include cell size and composition, membrane structure and sample availability of ~20 embryos per mouse, equivalent to less than 1 g of protein [25] [26] [27] [28] . To complement the repertoire of existing measurements and resolve the intriguing questions surrounding mammalian development, such as when the first cell fate decisions are made, precision protein tools with higher selectivity are needed.
Here we report microfluidic immunoblotting for direct analysis of proteoforms across all stages of mouse preimplantation, from whole embryos to single blastomeres. With a dynamic detection range spanning two-orders of magnitude (oocytes at 10 -15 mole to blastocyst blastomeres at 10 -17 mole), we scrutinize widely used housekeeping proteins (-tubulin, -actinin, and GAPDH), embryo-specific isoforms (DICER-1) and regulators of cell fate decisions (SOX-2 and GADD45a). In whole morula, we assess expression of three targets (GAPDH, CDX-2 and SOX-2) having small 1-2 kDa differences in molecular mass. Applied to the study of intra-embryonic heterogeneity, we observe statistically significant differences in GADD45a expression at the four-cell and even two-cell stages. Microfluidic immunoblotting provides the resolution necessary to quantifiably investigate both inter-and intra-embryonic heterogeneity.
Results

Microfluidic immunoblotting of single embryos and single blastomeres
We first sought to directly measure protein expression in cells ranging from single oocytes (~80 m in diameter) to single blastomeres from disaggregated blastocysts (<20 m in diameter at 3.5-4.0 days post coitus, dpc) ( Fig. 1a ). Sample preparation of harvested murine embryos includes (i) removal of the zona pellucida by incubating with acidic Tyrode's solution and, if studying disaggregated blastomeres, (ii) dissociation of embryos into individual blastomeres by incubation with trypsin and Accutase®. The microfluidic immunoblot, comprised of a 100-150 µm-thick polyacrylamide (PA) gel layered on a glass microscope slide, is stippled with an array of microwells (100-160 µm in diameter), where each microwell is designed to isolate an individual embryo or blastomere, depending on the assay. Using a standard mouth-controlled capillary tube assembly 29 , single embryos or blastomeres are seated into individual microwells ( Fig. 1b ). Once isolated in each microwell, cell samples are chemically lysed (60-70 s). An electric field (E = 40 V/cm; 35-75 s) is applied to drive protein polyacrylamide gel electrophoresis (PAGE) in a 3 mmlong separation lane abutting each lysate-containing microwell. Protein blotting (immobilization) to the PA gel is achieved by UV-mediated activation of benzophenone methacrylamide moieties crosslinked into the gel matrix. Size-resolved immobilized protein bands are probed using primary antibodies and fluorophore-conjugated secondary antibodies, resulting in single-embryo or single-blastomere immunoblots. By probing for the protein loading control -tubulin in lysate from single oocytes down to individual blastomeres from a disaggregated blastocyst ( Fig. 1c ), we determined a dynamic detection range spanning femtomoles (10 -15 ) to tens of attomoles (10 -17 ), assuming a starting protein target concentration in the M range 30 .
We next scrutinized single morula (3.0 dpc) for SOX-2 and CDX-2, two transcription factors that regulate pluripotency and differentiation 31, 32 , and the loading control GAPDH. SOX-2, CDX-2 and GAPDH have molecular masses of 37, 38 and 39 kDa, respectively ( Fig. 1d ). By employing a combination of (i) primary antibodies raised in different animals (goat-anti-GAPDH, rabbit-anti-SOX-2, and mouse-anti-CDX-2), (ii) secondary antibodies conjugated to different fluorophores (donkey-anti-goat, rabbit and mouse conjugated to AlexaFluor 555, 488 and 594, respectively), and (iii) reprobing after gel stripping using a reducing stripping buffer, the microfluidic immunoblot resolved all three targets from intact morula. The observed log-linear relationship between molecular mass and migration distance ( Fig. 1d ) enables distinguishing target protein bands from non-specific antibody signal and demonstrates that single-morula PAGE resolves protein targets with molecular mass as close as 1-2 kDa.
Single-embryo and single-blastomere immunoblotting detects biological variation
Given our ability to immunoblot dissociated blastomeres, we next examined (i) if embryo disaggregation artificially alters the protein abundance of the whole embryo and (ii) if we can reconstruct the expression profile of the whole embryo, even when constituent blastomeres are assayed individually.
We first inquired if loading a pre-determined increase of protein in the microfluidic immunoblot would yield a concomitant increase in protein signal. We thus performed titrations where we controlled loaded protein by using individual blastomeres from dissociated four-cell embryos (2.0 dpc) as discrete and easily manipulable loads of protein. We loaded either one or two blastomeres into microwells and assayed the microwell lysate for -tubulin ( Fig. 2a ). We observed a proportional increase in -tubulin expression (area-under-the-curve signal or AUC) from microwells loaded with two blastomeres as compared to microwells loaded with one blastomere (Mann Whitney U Test, p value = 6.28x10 -5 , with N = 7 and 11 microwells, respectively). The observation corroborates the supposition that two blastomeres would contain two-fold more protein than a single blastomere ( Fig. 2a ).
We next sought to assess if the protein profile of a whole embryo could be reconstructed from immunoblots of individual, dissociated blastomeres. To do so, we simultaneously assayed (i) intact individual four-cell embryos and (ii) blastomeres from disaggregated four-cell embryo (each blastomere contained in a separate microwell) ( Fig. 2b) . The resulting AUC for the -tubulin protein band was compared between the intact four-cell embryo and the summed immunoblot signal from the four disaggregated blastomeres. We observed no significant difference between the sum of the contributions of dissociated blastomeres and signal obtained from a four-cell embryo (Wilcoxon matched-pairs signed rank test, p value = 0.5, N = 3 independent experiments) ( Fig. 2b ), suggesting that immunoblotting of individual blastomeres can reconstruct the protein profile of the originating intact four-cell embryo.
Finally, we sought to assess if the source of the observed inter-blastomeric variation in -tubulin AUC was attributable to biological variation or confounding technical variation. First, we established a technical variation threshold by quantifying immunoblots of microwells uniformly loaded with purified protein. Briefly, we partitioned a solution of purified bovine serum albumin (BSA, 1 M in PBS) into the microwells by incubating PA gels in BSA solution for 30 min. We then performed the immunoblotting assay and quantified BSA protein band AUC. We calculated the coefficient of variation in BSA AUC (CVAUC % = AUC standard deviation (S.D.) / mean AUC x 100) and computed a technical variation threshold defined as > 3 x S.D. of the mean CVAUC 33 (CVthreshold = mean CVAUC + 3 S.D. = 7.4%, where mean CVAUC = 4.69% and S.D. = 0.92%, Fig. S1 ). For all dissociated four-cell embryos studied, the inter-blastomeric -tubulin expression CV exceeded the technical variation threshold (CVs = 8.3%, 19.6% and 11.3% for embryos, Fig. 2b ). Consequently, we attribute the inter-blastomeric variation to biological variation and not technical variation.
Normalization of SOX-2 expression by -tubulin is not equivalent to normalization by cell volume for morula blastomeres
RNA-Seq studies suggest that cells regulate transcription to maintain mRNA concentration in response to changes in cell volume 34, 35 . Thus, cellular mRNA concentration is a more accurate indicator of cell phenotype than cellular mRNA abundance 34, 35 . Normalizing by a loading control that is strongly correlated with cell size is therefore crucial for elucidating true phenotypic differences between cells. However, RNA-based studies show that commonly employed housekeeping genes (e.g., GAPDH and -tubulin) are not stably and homogeneously expressed across different samples, experimental conditions or treatments 36 . The issue is further exaggerated as the sample size diminishes, reducing the averaging effect of a larger pooled samples. Whether this variability, and thus unreliability, of loading controls for single-cell studies prevails at the protein level remains to be explored.
Hence, we next tested whether the widely-used loading control -tubulin is an accurate indicator of cell volume in preimplantation embryos. We assayed dissociated morula blastomeres for tubulin and compared -tubulin expression (AUC) to cell volume (computed from brightfield images of cells seated in microwells) ( Fig. 3a ). We noted a significant positive, linear correlation between cell volume and -tubulin expression (Pearson correlation,  = 0.8582, N = 8, p value = 0.0064) ( Fig. 3b ). To determine if this correlation indicates that -tubulin can be used as a proxy for cell volume, we examined whether normalizing SOX-2 expression by -tubulin expression is equivalent to normalizing by computed cell volume. We first observed that while SOX-2 expression showed significant positive correlation with cell volume (Pearson correlation,  = 0.7660, N = 8, p value = 0.0267) ( Fig. 3b ), SOX-2 expression normalized by -tubulin was not correlated with cell volume (negative association, Pearson correlation  = -0.5866, N = 7, p value = 0.1668) ( Fig. 3b ). Furthermore, SOX-2 normalized by cell volume was not significantly correlated with SOX-2 normalized by -tubulin (Pearson correlation,  = 0.5522, p value = 0.1558) ( Fig. 3b ).
Hence, careful validation of loading controls as accurate predictors of cell volume is indispensable, even if expression of loading controls is well correlated with cell volume. Indexing endpoint immunoblot results with micrographs of the originating and intact cell sample allows us to normalize target protein expression by cell volume -a normalization that is impossible in endpoint immunoblots of lysate from pooled cell populations.
Microfluidic immunoblotting detects truncated DICER-1 isoform expression in oocytes and two-cell embryos
Alternative splicing is frequent during early embryonic development in mouse and human [37] [38] [39] . However, efforts to investigate whether the corresponding alternate protein isoforms are ultimately and stably generated require pooling tens of thousands of collected embryos from each stage, losing intra-blastomeric information in the process 20 . Thus, single embryo and blastomere approaches capable of resolving proteoforms resulting from alternative splicing are needed.
To this end, we aimed to examine one of the earliest known examples of a protein isoform that exists in mouse development. DICER-1 is essential for small RNA-mediated gene expression regulation. By processing small RNAs into their mature form, DICER-1 generates the sequencespecific guides required by effector complexes to target cognate mRNAs and repress their translation 40 . Bulk analyses of mouse oocytes found high expression of an N-terminally truncated isoform, denoted DICER O (Fig. 4a ). DICER O demonstrates higher catalytic activity than its fulllength form (DICER-1) and is believed to drive the high activity of endogenous small interfering RNAs (endo-siRNAs) in mouse oocytes, but not in somatic cells 40 . The Dicer O transcript persists until the fertilized zygote stage, but it remains unclear whether the DICER O protein isoform is exclusive to oogenesis or is maternally inherited by the preimplantation embryo.
To explore whether DICER O is specific to the oocyte stage, we assayed oocytes and two-cell embryos for isoforms of DICER-1. We collected oocytes and two-cell embryos and divided each sample for analysis of either protein by microfluidic immunoblotting or mRNA analysis by singleembryo quantitative reverse transcription polymerase chain reaction (qRT-PCR) ( Fig. 4b ). Despite of a lack of an isoform-specific antibody, the electrophoretic separation of proteins resolved multiple DICER-1 isoforms by molecular mass. We observed that both oocytes and two-cell embryos expressed both the full-length and the truncated DICER-1 (Fig. 4c ). For oocytes, we observed significantly higher expression of the truncated isoform over the full-length DICER-1 for both mRNA (normalized by endogenous control Rfx1) and protein (AUC) (for mRNA/Rfx1 DICER-1 vs. mRNA/Rfx1DICER o : Mann-Whitney U test, p value = 0.0052 for N = 18; for AUCDICER-1 vs. AUCDICER o : Mann-Whitney U test, p value = 0.0079 for N = 5) ( Fig. 4d ). On the other hand, we found no significant difference in expression of truncated and full-length isoforms of DICER-1 in two-cell embryos (for mRNA/Rfx1DICER-1 vs. mRNA/Rfx1DICER o : Mann-Whitney U test, p value = 0.9551 for N = 7 for DICER-1 and N = 8 for DICER O ; for AUCDICER-1 vs. AUCDICER o : Mann-Whitney U test, p value = 0.20 for N = 4) ( Fig. 4d ). When comparing expression levels between embryonic stages, we observed that for both mRNA and protein the expression of full-length DICER-1 was not significantly different between oocytes and two-cell embryos (mRNA/Rfx1DICER-1: Mann Whitney U test, p value = 0.084 for N = 18 oocytes and 7 two-cell embryos; AUCDICER-1: Mann Whitney U test, p value = 0.9048 for N= 5 oocytes and 4 two-cell embryos) ( Fig. 4d ). For the truncated isoform, however, we observed a significant decrease in both mRNA levels and protein levels from the oocyte to the two-cell stage (mRNA/Rfx1DICER O : Mann Whitney U test, p value = 0.0004 for N = 18 oocytes and 8 two-cells; AUCDICER O : Mann Whitney U test, p value = 0.0159 for N = 5 oocytes and 4 two-cell embryos) ( Fig. 4d ). Hence, protein PAGE from single-embryo lysates grants the selectivity required for measuring protein isoforms, even when pan-specific antibodies are the only reagent available.
Single-blastomere immunoblotting reports GADD45a expression heterogeneity in two-and four-cell embryos
We finally sought to inspect early-stage embryos for lineage biases by measuring protein expression from disaggregated two-cell and four-cell embryos. The exact stage and circumstances by which blastomeres acquire certain fates remains unknown. On the one hand, it is thought that embryonic plasticity supports blastomere symmetry up to the 8-cell embryo, where embryos can compensate for the loss of one blastomere as early as the two-cell stage 41 . On the other hand, studies point to early asymmetry, where sister blastomeres show consistent bimodal expression of genes related to differentiation, suggesting that the involved factors may not be inherited equally by all blastomeres 6 .
As such, to quantitatively examine intra-embryonic heterogeneity in cell fate related markers, we assayed early-stage blastomeres for GADD45a, a protein involved in DNA damage repair that has been reported to show bimodal transcription at the two-cell and four-cell stages 4 (Fig. 5a ). We compared the intra-embryonic heterogeneity of GADD45a expression to that of -tubulin, to control for stochasticity of protein partitioning at cell division 42 (Fig. 5b ). We observed that the intra-embryonic variation in GADD45a expression is significantly higher than the variation in tubulin expression (CVGADD45a = 31.5  13.5%; CVb-tub = 13.4  5.4%; mean  S.D., Wilcoxon signedrank test, p value = 0.0312, N = 6, where all CVs > CVthreshold of 7.4%, indicating that the measured heterogeneity is attributable to biological, not technical, variation) ( Fig. 5c & d) . These findings suggest that blastomeres of four-cell embryos show heterogeneous expression of GADD45a, in agreement with the mRNA and IF-based findings of Biase et al. 4 .
We next investigated if heterogeneity in GADD45a expression arises in the earlier two-cell embryo. Unlike in the four-cell stage, bimodality in GADD45a protein expression at the two-cell stage remains unexplored. We thus assayed dissociated two-cell embryos to understand the intra-embryonic distribution of GADD45a. To test whether one blastomere consistently showed higher GADD45a AUC than the other, we immunoblotted dissociated two-cell blastomeres for GADD45a and -tubulin ( Fig. 5e and f) and computed the ratio of expression between the blastomere with high expression and low expression for both markers (Fig. 5g ). We found that the ratio of high-to-low GADD45a expression (1.26  0.109) is significantly larger than the highto-low ratio for -tubulin (1.16  0.11; mean  S.D., paired t test p value = 0.0251, N = 11 twocell embryos, distributions for GADD45a and β-tubulin passed the D'Agostino & Pearson normality test with p values = 0.6842 and 0.2497, respectively) ( Fig. 5h ). Hence, we posit that two-cell blastomeres display significant heterogeneity in GADD45a protein expression, providing protein-based evidence for heterogeneity in GADD45a expression even at the earliest multicellular preimplantation stage. Functional studies will allow us to determine whether differences in GADD5a protein expression levels are indicative of differential cellular phenotypes.
Discussion
Open questions surround the timing and mechanism by which the first cell fate decisions are made during mammalian pre-implantation development. Do developing blastomeres remain homogeneous and functionally equivalent until the compacted morula stage 1,2 ? Or, alternately, do these developing blastomeres exhibit symmetry-breaking heterogeneous configurations, perhaps as early as the two-cell stage 7, [9] [10] [11] ? In mice, zygotic genome activation (ZGA) occurs shortly after fertilization and is not fully realized until the two-cell stage, at which point nascent mRNA populate the embryonic transcriptome 43 . While recent single-cell RNA-Seq experiments reveal sister blastomere transcriptome heterogeneity as early as the two-cell embryo in both human and mice 4, 11 , functional studies suggest these differences may not matter until the fourcell stage 3, 12 .
Here, microfluidic design provides an avenue for a cellular-resolution form of protein immunoblotting applicable to mammalian development as early as the oocyte stage of a murine model. To advance linking mRNA levels to protein expression when tackling questions on cell fate determination, we scrutinized two-cell and four-cell embryos for signs of heterogeneity in protein expression of GADD45a, a gene shown to be bimodally transcribed in early embryonic stages. The microfluidic immunoblot detects higher heterogeneity in GADD45a expression than loading control -tubulin between the blastomeres in early embryos, providing the first proteinbased validation of recent single cell RNA-Seq predictions. Companion functional competency measurements guided by the ever-increasing resolution of single-cell transcript approaches will help in determining the proteins and isoforms involved in key cell fate decisions event.
Directly scrutinizing and independently validating single-cell transcriptional data describing early embryonic development requires direct measurement of proteins with single-cell resolution. The asynchrony observed between mRNA and protein expression may simply reflect the uncoupled relationship between transcription and translation in the early embryo (~15 hr), synchronizing more tightly in later cleavage stages 44 . Transcript abundance is not an accurate determinant of protein abundance 45, 46 , and whether the required activating post translational modifications (PTMs) are present has been difficult to ascertain 47 . Beyond PTMs and protein-mediated signaling, isoforms of proteins such as DICER1 are involved in regulation of small RNA-mediated gene expression. Microfluidic immunoblotting resolved DICER-1 isoforms in single oocytes and two-cell embryos, with the truncated DICER-1 protein isoform as the dominant isoform in the oocyte stage. Significantly lower abundance of the truncated DICER-1 mRNA and protein in twocell embryos compared to oocytes suggests that these may be inherited from the oocyte stage. These findings support previous studies suggesting that the truncated DICER-1 isoform, which shows higher activity than the full-length DICER-1, is oocyte-specific. Previously unattainable single-embryo lysate protein separations enable resolving and quantifying protein isoforms, even when isoform-specific antibodies are not available.
As detailed here, the ~20 embryos harvested from a single mouse donor are sufficient not just for one immunoblot, but for multiple single-embryo and single-blastomere immunoblots. The precision in sample handling and in enhanced sensitivity notably reduces the conventional PAGE sample requirements of several hundreds or thousands of embryos 20, 40 . The implications are multi-fold. First, as single-embryo immunoblots inherently and dramatically lower sample requirements, the burden of animal sacrifice is likewise reduced. Second, statistical interpretation of single-embryo and single-blastomere immunoblot results is feasible, revealing intra-embryonic heterogeneity, as well as significant differences between embryos of the same fertilization event and between donors.
Lastly arises the possibility of companion immunoblot and mRNA assays on embryos of the same donor, thus enhancing the biological accuracy of correlations between mRNA levels and protein expression at different stages of the preimplantation embryo. Such insight into the expression dynamics would clarify how modulation in transcription dictates cellular phenotype 48 . Moreover, with the advent of new gene editing technologies, (e.g., CRISPR, genomic screening methods including targeted, exome or whole genome sequencing) screening for off-target activity has become critical 49 . Protein assays that can complement genomic screening, such as the one described in this study, will be crucial for screening embryos for protein-level effects of both ontarget and off-target mutations, even when the latter occur in non-coding regions.
Methods
Animals and Ethics Statement
As a matter of caution and compliance, all appropriate authorizations have been acquired from institutional and/or federal regulatory bodies prior to performing this protocol. All mouse use, including but not limited to housing, breeding, production, sample collection for genotyping, and euthanasia, is in accordance with the Animal Welfare Act, the AVMA Guidelines on Euthanasia and are in compliance with the ILAR Guide for Care and Use of Laboratory Animals, and the UC Berkeley Institutional Animal Care and Use Committee (IACUC) guidelines and policies. Our animal care and use protocol has been reviewed and approved by our IACUC for this project. 
Chemical Reagents
Device Fabrication
Devices were fabricated using SU-8 wafers as previously reported. Microwell height and diameter were varied to accommodate different embryo stages (microwell diameters ranged from 20 m for dissociated blastocyst blastomeres to 150 m for oocytes, with height maintaining an aspect ratio of 1.3). Polyacrylamide precursor solution including acrylamide/bis-acrylamide (7-12%T) and 3 mM BPMAC was degassed with sonication for 9 min. 0.08% APS and 0.08% TEMED were added to precursor solution and solution was pipetted between the SU-8 wafer (rendered hydrophobic with Gel Slick TM solution) and a glass microscope slide functionalized with 3-(trimethoxylsilyl)propyl methacrylate (to ensure covalent grafting of PA gel to glass surface). After chemical polymerization (20 min), devices (glass with grafted PA gel layer) were lifted from wafer, rinsed with deionized water and stored dry until use.
Mouse Embryo Isolation and Culture
Three-to-five-week-old female C57BL/6J mice (000664, Jackson Laboratory) were superovulated by intraperitoneal (IP) injection of 5IU of Pregnant Mare Serum Gonadotropin (PMSG, Calbiochem, 367222, Millipore) and 46-48 hours later, IP injection of 5IU Human Chorion Gonadotropin (hCG, Calbiochem, 230734, Millipore). Superovulated females were housed at a 1:1 ratio with 3-8 month old C57BL/6J males to generate 1-cell zygotes at 0.5 days post coitum.
Using forceps under a stereomicroscope (Nikon SMZ-U or equivalent), the ampulla of oviduct was nicked, releasing fertilized zygotes and oocytes associated with surrounding cumulus cells into 50 l M2 + BSA media (M2 media (MR-015-D, Millipore) supplemented with 4 mg/mL bovine serum albumin (BSA, A3311, Sigma)). Using a handheld pipette set to 50 L, zygotes were dissociated from cumulus cells after the cumulus oocyte complexes were transferred into a 200 μl droplet of Hyaluronidase/M2 solution (MR-051-F, Millipore), incubated for up to 2 min, and passed through five washes in the M2+BSA media to remove cumulus cells.
From this point on, embryos were manipulated using a mouth-controlled assembly consisting of a capillary pulled from glass capillary tubes (P0674, Sigma) over an open flame attached to a 15inch aspirator tube (A5177, Sigma). Embryos were passed through five washes of M2+BSA to remove cumulus cells. Embryos were then transferred to KSOM + BSA media (KCl-enriched simplex optimization medium with amino acid supplement, ZEKS-050, Zenith Biotech) that was equilibrated to final culturing conditions at least 3-4 hr prior to incubation. Embryos were cultured in 20 μl droplets of KSOM + BSA overlaid with mineral oil (ES-005-C, Millipore) in 35 × 10 mm culture dishes (627160, CellStar Greiner Bio-One) in a water-jacketed CO2 incubator (5% CO2, 37 °C and 95% humidity).
Single-Embryo Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR)
All single embryo cDNA was prepared using a modified version of the Single Cell-to-Ct qRT-PCR kit (4458236, Life Technologies). Whole embryos were isolated at the desired developmental stage. Using a mouth pipette, embryos were then passed through three washes of PBS. With a hand-held pipette set to 1 L, a single embryo was collected and transferred to one tube of an 8 well PCR strip. Presence of embryo was visually confirmed in each tube prior to cDNA synthesis. To account for the larger sample input, twice the protocol recommended volume of Lysis/DNAse (20 L) was added to each embryo and allowed to incubate at room temperature (RT) for 15 minutes. Then, 2 L of Stop Solution was added and incubated for 2 min. At this point, half of the reaction was stored in -80 o C conditions as a technical replicate and the remaining sample (11 L) continued through the original Single Cell-to-Ct protocol. All qRT-PCR reactions were performed using SSO Universal SYBR Green SuperMix, as per manufacturer instructions (1725275, BioRad). Primer sequences used were Rfx1 (5'AGT GAG GCT CCA CCA CTG GCC G, 5'TGG GCA GCC GCT TCT C), Dicer-1 (5'GGA TGC GAT GTG CTA TCT GGA, 5'GCA CTG CTC CGT GTG CAA) and Dicer o (5'CTC TTT CCT TTG AAT GTA CAG CTA C, 5'CAG TAA GCA GCG CCC CTC). All qRt-PCR analyses were performed on the StepOnePlus Real Time PCR system (437660, Thermo).
Single-Embryo and Single-Blastomere Microfluidic Immunoblotting
Once the desired developmental stage was reached, embryos were transferred to a ~50 L droplet of acid Tyrode's Solution (T1788, Sigma) and incubated at 37 o C for up to 2 min to remove the zona pellucida. If dissociation into blastomeres was required, embryos were first incubated with a 1:1 solution of Accutase® and 10X trypsin (15090046, Thermo) at 37 o C (time varied with development stage, ranging from 5 min for two-cell embryos to up to 5 hr for blastocysts). Embryos were then mechanically disrupted by passing embryo through capillary repeatedly until dissociation. Single embryos or blastomeres were washed with PBS and deposited into microwells of the PA gel. Microwells were imaged by brightfield microscopy to collect data on size, morphology and ensure occupancies of one embryo or blastomere per microwell. Lysis conditions, including buffer composition, temperature and treatment time, were optimized for each developmental stage (Table S1 ). Electrophoresis was performed at 40 V/cm for varying times (from 20 to 60 s, depending on developmental stage and protein targets). Immobilization of proteins by photocapture was carried out by illumination with UV light source (100% power, 45 s, Lightningcure LC5, Hamamatsu). Gels were washed in 1X TBST for at least 1 hr before probing with antibodies. Primary antibodies were incubated at 1:10 dilution (40 L/gel, in 2% BSA in 1X TBST), while fluorophore-conjugated secondary antibodies were incubated at 1:20 dilution (40 L/gel, in 2% BSA in TBST). In order to strip bound antibodies and reprobe for new targets, gels were treated with 2% SDS, 0.8% -mercaptoethanol and 62.5 mM Tris base at 55 o C for three hours, washed in TBST (1 hr) twice and then reprobed.
Antibodies
Antibodies employed for analysis of embryos include: rabbit anti--Tubulin (Abcam, ab6046, polyclonal, LOT: GR31927-5), mouse anti-Dicer-1 (Santa Cruz, sc-136981, A-2, LOT: I1817), mouse anti-CDX-2 (Abcam, ab157524, CDX2-88, LOT: GR300552-6), rabbit anti-SOX-2 (EMD Millipore, AB5603, polyclonal, LOT: NG1863962), goat anti-GAPDH (Sigma, SAB2500450, polyclonal, LOT: 6377C2), rabbit anti-GADD45a (Invitrogen, MA5-17014, D.81.E, LOT: R12274975). Donkey secondary antibodies AlexaFluor 647-conjugated anti-mouse (A31571), AlexaFluor 594conjugated anti-mouse (A21203) and AlexaFluor 488-conjugated anti-rabbit (A21206) were purchased from ThermoFisher Scientific CA, USA.
Image Processing, Signal Quantification and Statistical Analysis
The datasets generated during and analyzed during the current study are available from the corresponding author on reasonable request. Statistical tests were performed using GraphPad Prism 7.0b. Quantification of fluorescence signal of protein immunoblots employed in-house scripts written in MATLAB (R2017a, Mathworks) 33 . Briefly, Gaussian curves were fitted to protein band fluorescence intensity profiles using MATLAB's Curve Fitting Toolbox. Gaussian fit parameters of protein peak location and  were used to compute area-under-the-curve (AUC) by integrating the fluorescence intensity profile for the peak width defined as 4. Fiji (ImageJ) was used to false-color fluorescence micrographs and overlay channels to create composite images. ImageJ was used to compute cell volume 50 . Briefly, cell boundaries were traced using the freehand selection tool. For area traces with circularity of > 0.9, we assumed spherical morphology, computed cell diameter () from traced area and cell volume was calculated from the computed cell diameter. 
